Project Inform's PI Perspective eNews: March 2009

---- in this issue ----

Project Inform calls for greater commitment to cure

REMINDER: Martin Delaney memorial scheduled

SF HCV/HIV forum slated

Acyclovir: the next new HIV drug?

Project Inform applauds app't of Jeffrey Crowley

Two newcomers challenge ritonavir’s position

Risk for invasive anal cancer high for HIV+ people

1 of 10 ways to support Project Inform’s mission

newest publications
from Project Inform

Coverage from CROI 2009

PI Perspective #47

March 2009 | projectinform.org

Project Inform

Project Inform joins call for greater commitment and cooperation to identify a cure for HIV/AIDS

A group of leading HIV experts has assembled to call for a major new commit-ment and better collaboration among government, industry, academic, and patient advocacy leaders to identify therapies that will actually cure HIV infection, or drive it into remission, as reported in Science magazine. The article is co-authored by Founding Director, Martin Delaney. Read more.

REMINDER: Memorial slated for Martin Delaney's life, March 14

The memorial and celebration of Martin Delaney, Project Inform's co-founder, will take place Saturday, March 14, in San Francisco. The event will be held at the Eureka Valley Recreation Center starting at 4:30pm. Public transporation is strongly encouraged. Read more.

Acyclovir: the next new HIV drug?

At CROI 2009 in Montreal, Canada, acyclovir—a drug used to treat herpes—
shows that it also inhibits HIV during a step in the virus’s life cycle. Two studies looked at how acyclovir affected HIV, which may pave the way to using it to treat HIV either on its own or together with herpes therapy. Read more.

Risk for invasive anal cancer high among HIV-positive people.

At CROI 2009 in Montreal, Canada, a study reported more sobering news on the rate of anal cancer. Unlike other diseases that have declined in incidence since the advent of HAART, the appearance of this condition (caused by the human papillomavirus) has continued to increase since the beginning of HAART. Read more.

SF community forum on HIV and hepatitis C co-infection.

Event is slated for March 17, from 6:30–8:30pm and is co-sponsored by the Conant Foundation, Black Coalition on AIDS, and Project Inform. The event is free and follows a similar forum that was held in January. Read more.

Project Inform applauds appointment of Jeffrey Crowley.

President Obama's choice as the new Director of the Office of National AIDS Policy reflects his commitment to combating the domestic AIDS epidemic. Read more.

1 of 10 ways to support Project Inform’s mission.

With more than 50,000 new infections occurring annually in the US, it's imperative Project Inform maintain its focus to impact the health of those living with HIV and the rising tide of new infections. Read more.

Two newcomers may challenge ritonavir’s position as the only booster for HIV therapy.

At CROI 2009 in Montreal, Canada, two companies announced the develop-ment of new boosters for HIV therapy that could replace ritonavir’s sole position in that role. Read more.